European Biotech Acquisition Stock Price, News & Analysis
Company Description
European Biotech Acquisition (NASDAQ: EBACU) is a publicly traded shell companies company in the Financial Services sector.
EBACU stock has gained 14.7% over the past year.
This page provides a comprehensive overview of EBACU stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
European Biotech Acquisition (EBACU) stock. Over the past 12 months, the stock has gained 14.7%.
Latest News
European Biotech Acquisition has 3 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 1 with negative movement. Key topics include acquisition, IPO, offering. View all EBACU news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
EBACU Company Profile & Sector Positioning
European Biotech Acquisition (EBACU) operates in the Shell Companies industry within the broader Financial Services sector and is listed on the NASDAQ.
Investors comparing EBACU often look at related companies in the same sector, including ARMADA ACQUISITION CORP III (AACIU), ARMADA ACQUISITION CORP III (AACIW), Ace Convergence Acqu Corp (ACEVU), Independence Holdings Corp (ACQRU), and Arclight Clean Transition Corp Ii (ACTDU). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate EBACU's relative position within its industry.